Medically reviewed by Lindsay Cook, PharmD Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose), ...

The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based therapy is a promising novel treatment of type 2 diabetes, the strategy to ...

A class of drugs used to treat diabetes, called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, cut the risk of a type 2 diabetes ... called a dipeptidyl peptidase-4 (DPP-4) inhibitor.

Patients with type 2 diabetes may have the lowest risk ... 3 CKD and were starting diabetes treatment using a dipeptidyl peptidase-4 inhibitor (DPP-4i), SGLT2i, GLP-1RA, or sulfonylurea (SU).